DANIEL MUSHER to Follow-Up Studies
This is a "connection" page, showing publications DANIEL MUSHER has written about Follow-Up Studies.
Connection Strength
0.195
-
Antibody persistence ten years after first and second doses of 23-valent pneumococcal polysaccharide vaccine, and immunogenicity and safety of second and third doses in older adults. Hum Vaccin. 2011 Sep; 7(9):919-28.
Score: 0.050
-
The long-term outcome of treatment of Clostridium difficile colitis. Clin Infect Dis. 2007 Aug 15; 45(4):523-4.
Score: 0.038
-
The association between pneumococcal pneumonia and acute cardiac events. Clin Infect Dis. 2007 Jul 15; 45(2):158-65.
Score: 0.037
-
Relatively poor outcome after treatment of Clostridium difficile colitis with metronidazole. Clin Infect Dis. 2005 Jun 01; 40(11):1586-90.
Score: 0.032
-
Predictive and prognostic factors in patients with blood-culture-positive community-acquired pneumococcal pneumonia. Eur Respir J. 2016 09; 48(3):797-807.
Score: 0.017
-
Cardiac complications in patients with community-acquired pneumonia: incidence, timing, risk factors, and association with short-term mortality. Circulation. 2012 Feb 14; 125(6):773-81.
Score: 0.013
-
Fever and infection in spinal cord injury patients. JAMA. 1982 Jul 02; 248(1):66-70.
Score: 0.007